CPT® adds 0283U to be reported only for Versiti™ VWD Type 2B Evaluation from Versiti™ Diagnostic Laboratories on a plasma specimen to evaluate von Willebrand disease (VWD) Type 2B platelet binding and multimer levels to differentiate different types of VWD.
Effective date of this code: October 1, 2021.
For clinical responsibility, terminology, tips and additional info
start codify free trial.